Astellas and Ironwood report positive top-line results from phase III linaclotide trial

Astellas Pharma Inc and Ironwood Pharmaceuticals Inc announced top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint.

Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes in new research centre

University of Oxford and Novo Nordisk announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and University of Oxford to collaborate to discover innovative approaches...

Mallinckrodt completes sale of Its Nuclear Imaging business to IBA Molecular

Mallinckrodt plc , a leading specialty pharmaceutical company, announced that it has closed the sale of its global Nuclear Imaging business to IBA Molecular for approximately $690 million before tax, including up-front and contingent considerations...

IBM Watson Health and Lundbeck form collaboration on technology for developing innovative medicine

Lundbeck A/S is collaborating with IBM Watson Health to accelerate the development of innovative medicines to treat psychiatric and neurological disorders.

Kraig Biocraft laboratories expands domestic dragon silktm production capacity with new texas location

Kraig Biocraft Laboratories , the leading developer of spider silk based fibers announced it had secured a long term property lease in Texas for the Companys domestic mulberry production.

Beximco Pharma forms JV with Malaysia-based BioCare manufacturing

Beximco Pharma Limited the fast-growing manufacturer of generic pharmaceutical products announces the creation of a joint venture with BioCare Manufacturing Sdn Bhd based in Malaysia.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com